L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare 28 day mortality rates between septic shock
patients with acute renal insufficiency treated via L-Carnitine (as an adjunct therapy)
versus a similar group of patients not receiving L-Carnitine adjunct therapy.